Pfizer Launches 3g Unasyn Vial In Japan For Easier Administration Of High Doses
This article was originally published in PharmAsia News
Executive Summary
Pfizer Japan will launch a new 3g vial of the β-lactamase inhibitor combination antibiotic Unasyn (sulbactam sodium/ampicillin sodium) June 7.